英文名稱 |
中文名稱 |
CAS號 |
操作 |
EAI001 |
2-(1-氧代異吲哚啉-2-基)-2-苯基-N-(噻唑-2-基)乙酰胺 |
892772-75-7 |
詳細(xì)
|
Simotinib |
Simotinib |
944258-89-3 |
詳細(xì)
|
Canertinib |
卡奈替尼 |
267243-28-7 |
詳細(xì)
|
Pyrotinib dimaleate |
馬來酸吡咯替尼 |
1397922-61-0 |
詳細(xì)
|
Theliatinib |
席栗替尼 |
1353644-70-8 |
詳細(xì)
|
ARRY-380 analog |
ARRY-380 |
937265-83-3 |
詳細(xì)
|
Lazertinib |
YH-25448 |
1903008-80-9 |
詳細(xì)
|
Rezivertinib |
REZIVERTINIB |
1835667-12-3 |
詳細(xì)
|
TAS0728 |
TAS0728 |
2088323-16-2 |
詳細(xì)
|
Zipalertinib |
齊帕勒替尼 |
1661854-97-2 |
詳細(xì)
|
Almonertinib |
阿美替尼 |
1899921-05-1 |
詳細(xì)
|
Almonertinib mesylate |
阿美替尼甲磺酸鹽 |
2134096-06-1 |
詳細(xì)
|
Alflutinib mesylate |
AST2818甲磺酸鹽 |
2130958-55-1 |
詳細(xì)
|
PKI-166 |
PKI 166 |
187724-61-4 |
詳細(xì)
|
Tyrphostin AG30 |
酪氨酸磷酸化抑制劑 AG 30 |
122520-79-0 |
詳細(xì)
|
JND3229 |
JND3229 |
2260886-64-2 |
詳細(xì)
|
Pomalidomide-amino-PEG5-NH2 hydrochloride |
泊馬度胺-五聚乙二醇-氨基鹽酸鹽 |
2421217-05-0 |
詳細(xì)
|
Pomalidomide-amino-PEG3-NH2 hydrochloride |
POMALIDOMIDE-PEG3-NH2鹽酸鹽 |
2380273-75-4 |
詳細(xì)
|
Thalidomide-piperazine-Boc |
1-Piperazinecarboxylic acid, 4-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-5-yl]-, 1,1-dimethylethyl ester |
2222114-64-7 |
詳細(xì)
|
Thalidomide 4'-ether-alkylC2-amine hydrochloride |
Thalidomide-linker 6 |
2341840-99-9 |
詳細(xì)
|
Thalidomide-NH-PEG3-propionic acid |
Pomalidomide-PEG3-CO2H |
2138440-82-9 |
詳細(xì)
|
(S,R,S)-AHPC-phenol-C4-NH2 dihydrochloride |
(S,R,S)-AHPC-PHENOL-C4-NH2 (DIHYDROCHLORIDE) |
2376990-26-8 |
詳細(xì)
|
Pomalidomide-PEG1-C2-COOH |
POMALIDOMIDE-PEG 1-CO 2 H |
2139348-60-8 |
詳細(xì)
|
Thalidomide-Piperazine-PEG1-COOH |
|
2731007-11-5 |
詳細(xì)
|
Pomalidomide-PEG4-C-COOH |
E3 Ligase Ligand-Linker Conjugates 1 |
2097938-44-6 |
詳細(xì)
|
MRT00033659 |
MRT00033659 |
1401731-54-1 |
詳細(xì)
|
HLM006474 |
CS-1224 |
353519-63-8 |
詳細(xì)
|
GSK682753A |
1334294-76-6 |
1334294-76-6 |
詳細(xì)
|
ML401 |
ML401 |
1597489-14-9 |
詳細(xì)
|
NIBR189 |
NIBR189 |
1599432-08-2 |
詳細(xì)
|
EAI045 |
EAI-045 |
1942114-09-1 |
詳細(xì)
|
Gefitinib-based PROTAC 3 |
Gefitinib-based PROTAC 3 |
2230821-27-7 |
詳細(xì)
|
RTC-5 |
RTC-5 |
1423077-49-9 |
詳細(xì)
|
Nazartinib |
EGF816 |
1508250-71-2 |
詳細(xì)
|
EGFR-IN-7 |
5-溴-N4-[5-(二甲基膦基)-6-喹喔啉基]-N2-[2-甲氧基-5-甲基-4-[4-(4-甲基-1-哌嗪基)-1-哌啶基]苯基]-2,4-嘧啶二胺 |
2267329-76-8 |
詳細(xì)
|
BI-4020 |
RESATORVID |
2664214-60-0 |
詳細(xì)
|
Mavelertinib |
PF-06747775 |
1776112-90-3 |
詳細(xì)
|
EGFR-IN-11 |
EGFR-IN-11 |
2463200-44-2 |
詳細(xì)
|
Trastuzumab deruxtecan |
Trastuzumab Deruxtecan |
1826843-81-5 |
詳細(xì)
|
Lapatinib ditosylate monohydrate |
二甲苯磺酸拉帕替尼 |
388082-78-8 |
詳細(xì)
|
Lapatinib-d4 |
Lapatinib-d4 |
1184263-99-7 |
詳細(xì)
|
AZ7550 Mesylate |
AZ7550 Mesylate |
2319837-99-3 |
詳細(xì)
|
(E/Z)-AG490 |
酪氨酸磷酸化抑制劑AG490 |
134036-52-5 |
詳細(xì)
|
AG-18 |
酪氨酸磷酸化抑制劑23 |
118409-57-7 |
詳細(xì)
|
AP26113 |
AP26113 |
1197958-12-5 |
詳細(xì)
|
WZ8040 |
WZ8040 |
1214265-57-2 |
詳細(xì)
|
PD168393 |
PD168393 |
194423-15-9 |
詳細(xì)
|
CP-724714 |
2-甲氧基-N-[3-[4-[[3-甲基-4-[(6-甲基-3-吡啶基)氧基]苯基]氨基]-6-喹唑啉基]-2-丙烯-1-基]乙酰胺 |
537705-08-1 |
詳細(xì)
|
BMS-690514 |
(3R,4R)-4-氨基-1-[[4-[(3-甲氧基苯基)氨基]吡咯并[2,1-F][1,2,4]三嗪-5-基]甲基]哌啶-3-醇 |
859853-30-8 |
詳細(xì)
|
Gefitinib hydrochloride |
4-(3-氯-4-氟苯基氨基)-7-甲氧基-6-[3-(4-嗎啉基)丙氧基]喹唑啉鹽酸鹽 |
184475-55-6 |
詳細(xì)
|
Icotinib Hydrochloride |
凱美納 |
1204313-51-8 |
詳細(xì)
|
AEE788 (NVP-AEE788) |
6-[4-[(4-乙基-1-哌嗪)甲基]苯基]-N-[(1R)-1-苯基乙基]-7H-吡咯并[2,3-D]嘧啶-4-胺 |
497839-62-0 |
詳細(xì)
|
Thalidomide-O-C6-COOH |
Heptanoic acid, 7-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]- |
2169266-69-5 |
詳細(xì)
|
Thalidomide-O-amido-C3-PEG3-C1-NH2 |
沙利度胺-O-酰胺-C3-三聚乙二醇-C1-氨基 |
1799711-29-7 |
詳細(xì)
|
Pomalidomide-PEG2-COOH |
POMALIDOMIDE-PEG2-CO 2 H |
2140807-17-4 |
詳細(xì)
|
Pomalidomide 4'-PEG2-azide |
4-((2-(2-(2-azidoethoxy)ethoxy)ethyl)amino)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione |
2271036-45-2 |
詳細(xì)
|
Hydrocotarnine |
hydrocotarnine |
550-10-7 |
詳細(xì)
|
NSC689857 |
化合物 T25889 |
241127-79-7 |
詳細(xì)
|
Teslexivir hydrochloride |
BTA074 HYDROCHLORIDE ; AP 611074 HYDROCHLORIDE|||BTA074 HYDROCHLORIDE|||AP 611074 HYDROCHLORIDE |
1075281-70-7 |
詳細(xì)
|
MX69 |
MX69 |
1005264-47-0 |
詳細(xì)
|
(S,R,S)-AHPC-PEG2-N3 |
2010159-45-0 |
2010159-45-0 |
詳細(xì)
|
(S,R,S)-AHPC-PEG3-NH2 |
E3 ligase Ligand-Linker Conjugates 5 Free Base |
2010159-56-3 |
詳細(xì)
|
(S,R,S)-AHPC-PEG4-NH2 hydrochloride |
2064292-52-8 |
2064292-52-8 |
詳細(xì)
|
(S,R,S)-AHPC-(C3-PEG)2-C6-Cl |
1835705-61-7 |
1835705-61-7 |
詳細(xì)
|
Thalidomide-O-amido-PEG3-C2-NH2 TFA |
1957236-21-3 |
1957236-21-3 |
詳細(xì)
|
Thalidomide-O-amido-C3-COOH |
E3 ligase Ligand-Linker Conjugates 15 |
2308035-51-8 |
詳細(xì)
|
Thalidomide-O-amido-C4-NH2 TFA |
1799711-25-3 |
1799711-25-3 |
詳細(xì)
|
Thalidomide-O-amido-C8-NH2 TFA |
1950635-16-1 |
1950635-16-1 |
詳細(xì)
|
VH032-PEG5-C6-Cl |
1799506-06-1 |
1799506-06-1 |
詳細(xì)
|
Pomalidomide-PEG4-C2-NH2 hydrochloride |
泊馬度胺4'-PEG4-胺 |
2357105-92-9 |
詳細(xì)
|
Thalidomide-O-amido-PEG1-(C1-PEG)2-C2-NH2 TFA |
THALIDOMIDE-O-AMIDO-PEG1-(C1-?PEG)2-C2-NH2 |
2435572-49-7 |
詳細(xì)
|
Thalidomide-O-amido-C6-NH2 TFA |
1950635-14-9 |
1950635-14-9 |
詳細(xì)
|
Pomalidomide-PEG1-C2-N3 |
E3 ligase Ligand-Linker Conjugates 50 |
2271036-44-1 |
詳細(xì)
|
Pomalidomide-PEG3-C2-NH2 TFA |
沙利度胺-NH-PEG3-NH2 TFA |
2414913-97-4 |
詳細(xì)
|
Thalidomide-PEG2-C2-NH2 TFA |
Thalidomide-NH-PEG2-C2-NH2 (TFA) |
2097509-36-7 |
詳細(xì)
|
Thalidomide-NH-C6-NH2 TFA |
Thalidomide-NH-C6-NH2 TFA |
2093386-51-5 |
詳細(xì)
|
(S,R,S)-AHPC-PEG5-COOH |
E3 Ligase Ligand-Linker Conjugates 58 |
2172820-14-1 |
詳細(xì)
|
Thalidomide-NH-C4-NH-Boc |
泊馬度胺-NH-C4-氨基叔丁酯 |
2093388-52-2 |
詳細(xì)
|
PD153035 hydrochloride |
4-[(3-溴苯基)氨基]-6,7-二甲氧基喹啉 |
153436-54-5 |
詳細(xì)
|
AG-1478 |
AG1478 |
153436-53-4 |
詳細(xì)
|
Varlitinib (ARRY334543) |
泛EGFR小分子抑制劑(VARLITINIB) |
845272-21-1 |
詳細(xì)
|
AST-1306 |
AST-1306 |
897383-62-9 |
詳細(xì)
|
AST-1306 TsOH |
艾力替尼 |
1050500-29-2 |
詳細(xì)
|
Mutant EGFR inhibitor |
N-[5-[[5-氯-4-(1H-吲哚-3-基)-2-嘧啶基]氨基]-2-[[2-(二甲基氨基)乙基]甲基氨基]-4-甲氧基苯基]-2-丙烯酰胺 |
1421373-62-7 |
詳細(xì)
|
AZD-9291 (Mesylate) |
AZD9291(甲磺酸鹽) |
1421373-66-1 |
詳細(xì)
|
OSI-420 free base |
2-[[4-[(3-乙炔基苯基)氨基]-7-(2-甲氧基乙氧基)-6-喹唑啉基]氧基]乙醇 |
183321-86-0 |
詳細(xì)
|
AZD3759 |
AZD3759 |
1626387-80-1 |
詳細(xì)
|
RG 13022 |
RG-13022 |
136831-48-6 |
詳細(xì)
|
Compound 56 |
N-(3-溴苯基)-6,7-二乙氧基-4-喹唑啉胺 |
171745-13-4 |
詳細(xì)
|
AP-III-a4 |
AP-III-A4 |
1177827-73-4 |
詳細(xì)
|
Golgicide A-2 |
GOLGICIDE A-2 |
1394285-50-7 |
詳細(xì)
|
Rupintrivir |
(2E,4S)-4-[(2R,5S)-2-(4-氟芐基)-6-甲基-5-(5-甲基異惡唑-3-基甲酰氨基)-4-氧代庚酰氨基]-5-[[(3S)-2-氧代-3-吡咯烷基]-2-戊烯酸乙酯 |
223537-30-2 |
詳細(xì)
|
Pirodavir |
吡羅達韋 |
124436-59-5 |
詳細(xì)
|
Antiviral agent 24 |
N6-(3-Trifluoromethylbenzyl)adenosine |
23661-03-2 |
詳細(xì)
|
Pleconaril |
普可那利 |
153168-05-9 |
詳細(xì)
|
ONO-AE3-208 |
4-氰基-2-[[2-(4-氟-1-萘基)-1-氧代丙基]氨基]苯基丁酸 |
402473-54-5 |
詳細(xì)
|
UniPR129 |
化合物 T26310 |
1639159-47-9 |
詳細(xì)
|
NVP-BHG712 isomer |
NVP-BHG712 isomer |
2245892-85-5 |
詳細(xì)
|
JI-101 |
JI-101 |
900573-88-8 |
詳細(xì)
|
123C4 |
化合物123C4 |
2034159-30-1 |
詳細(xì)
|